PL3124016T3 - Przeciwłuszczycowa kompozycja emulsyjna zawierająca cefazolinę - Google Patents
Przeciwłuszczycowa kompozycja emulsyjna zawierająca cefazolinęInfo
- Publication number
- PL3124016T3 PL3124016T3 PL15460037T PL15460037T PL3124016T3 PL 3124016 T3 PL3124016 T3 PL 3124016T3 PL 15460037 T PL15460037 T PL 15460037T PL 15460037 T PL15460037 T PL 15460037T PL 3124016 T3 PL3124016 T3 PL 3124016T3
- Authority
- PL
- Poland
- Prior art keywords
- antipsoriatic
- cefazolin
- emulsion composition
- emulsion
- composition
- Prior art date
Links
- 230000002682 anti-psoriatic effect Effects 0.000 title 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 title 1
- 229960001139 cefazolin Drugs 0.000 title 1
- 239000000839 emulsion Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15460037.3A EP3124016B1 (en) | 2015-07-31 | 2015-07-31 | Antipsoriatic emulsion composition comprising cefazolin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3124016T3 true PL3124016T3 (pl) | 2020-04-30 |
Family
ID=54249423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15460037T PL3124016T3 (pl) | 2015-07-31 | 2015-07-31 | Przeciwłuszczycowa kompozycja emulsyjna zawierająca cefazolinę |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3124016B1 (pl) |
| DK (1) | DK3124016T3 (pl) |
| ES (1) | ES2760520T3 (pl) |
| PL (1) | PL3124016T3 (pl) |
| PT (1) | PT3124016T (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3064495B1 (fr) | 2017-03-31 | 2021-04-02 | Total Marketing Services | Composition a base d'uree pour le traitement des gaz d'echappement |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA502542A (en) | 1954-05-18 | E. Stirn Frank | Antibiotic ointment and preparation of same | |
| CA1165240A (en) | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| EP0103911A1 (en) | 1982-06-30 | 1984-03-28 | THE PROCTER & GAMBLE COMPANY | Emollient-containing topical pharmaceutical compositions |
| WO1991008733A1 (en) * | 1989-12-20 | 1991-06-27 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| CA2040460C (en) | 1990-05-01 | 1997-06-10 | Tacey X. Viegas | Drug delivery with thermoreversible gels |
| US5409917A (en) | 1991-03-05 | 1995-04-25 | Marvin S. Towsend | Topical treatment of acne with cephalosporins |
| SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
| US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6309663B1 (en) | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US20090053290A1 (en) | 2006-03-08 | 2009-02-26 | Sand Bruce J | Transdermal drug delivery compositions and topical compositions for application on the skin |
| CA2775393C (en) | 2012-05-02 | 2014-04-29 | Samy Saad | Topical non-aqueous pharmaceutical formulations |
| CA2877794C (en) * | 2012-06-29 | 2020-08-04 | Bayer Animalhealth Gmbh | Pharmaceutical compositions and treatment of mastitis |
| EP2774655A1 (en) * | 2013-03-05 | 2014-09-10 | JAO beheer BV | Composition comprising chicken eggshell particles, preparation and use |
| PL405506A1 (pl) | 2013-09-30 | 2015-04-13 | Warszawski Uniwersytet Medyczny | Zastosowanie pochodnej kwasu 7-aminocefalosporanowego jako inhibitora aktywności biologicznej IL-15 i IL-2 |
-
2015
- 2015-07-31 DK DK15460037T patent/DK3124016T3/da active
- 2015-07-31 PT PT154600373T patent/PT3124016T/pt unknown
- 2015-07-31 PL PL15460037T patent/PL3124016T3/pl unknown
- 2015-07-31 EP EP15460037.3A patent/EP3124016B1/en active Active
- 2015-07-31 ES ES15460037T patent/ES2760520T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3124016B1 (en) | 2019-09-04 |
| ES2760520T3 (es) | 2020-05-14 |
| EP3124016A1 (en) | 2017-02-01 |
| PT3124016T (pt) | 2019-12-13 |
| DK3124016T3 (da) | 2019-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2544435B (en) | Water-swellable lost circulation materials | |
| GB201512030D0 (en) | Composition | |
| GB201506827D0 (en) | Composition | |
| GB201505527D0 (en) | Composition | |
| GB201506825D0 (en) | Composition | |
| GB201506830D0 (en) | Composition | |
| GB201506829D0 (en) | Composition | |
| GB201515640D0 (en) | Composition | |
| GB201504665D0 (en) | Composition | |
| GB201517546D0 (en) | Composition | |
| SG10201912638VA (en) | Emulsion composition for skin | |
| GB201518348D0 (en) | Composition | |
| GB201515639D0 (en) | Composition | |
| GB201504307D0 (en) | Composition | |
| GB201519327D0 (en) | Composition | |
| GB201514585D0 (en) | Composition | |
| GB201506828D0 (en) | Composition | |
| GB201505520D0 (en) | Composition | |
| GB201511697D0 (en) | Composition | |
| GB201509044D0 (en) | Composition | |
| GB201508722D0 (en) | Composition | |
| GB201506826D0 (en) | Composition | |
| GB201521384D0 (en) | Composition | |
| GB201515734D0 (en) | Composition | |
| GB201509641D0 (en) | Composition |